Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash & Current Investments: 2020-2024

Historic Cash & Current Investments for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $1.9 million.

  • iSpecimen's Cash & Current Investments rose 58.85% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 47.38%. This contributed to the annual value of $1.9 million for FY2024, which is 62.47% down from last year.
  • As of FY2024, iSpecimen's Cash & Current Investments stood at $1.9 million, which was down 62.47% from $5.0 million recorded in FY2023.
  • Over the past 5 years, iSpecimen's Cash & Current Investments peaked at $27.7 million during FY2021, and registered a low of $695,909 during FY2020.
  • In the last 3 years, iSpecimen's Cash & Current Investments had a median value of $5.0 million in 2023 and averaged $7.4 million.
  • As far as peak fluctuations go, iSpecimen's Cash & Current Investments soared by 3,886.01% in 2021, and later plummeted by 67.30% in 2023.
  • Over the past 5 years, iSpecimen's Cash & Current Investments (Yearly) stood at $695,909 in 2020, then soared by 3,886.01% to $27.7 million in 2021, then crashed by 44.81% to $15.3 million in 2022, then tumbled by 67.30% to $5.0 million in 2023, then slumped by 62.47% to $1.9 million in 2024.